July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Targeting PEDF for the treatment of experimental autoimmune uveitis
Author Affiliations & Notes
  • Xiaomin Zhang
    Uveitis & Ocular Immunology, Tianjin Medical University Eye Hospital, Eye Institute & School of Optometry and Ophthalmology, China
  • Zhihui Zhang
    Uveitis & Ocular Immunology, Tianjin Medical University Eye Hospital, Eye Institute & School of Optometry and Ophthalmology, China
  • Shuang Chen
    Uveitis & Ocular Immunology, Tianjin Medical University Eye Hospital, Eye Institute & School of Optometry and Ophthalmology, China
  • Nu Chen
    Uveitis & Ocular Immunology, Tianjin Medical University Eye Hospital, Eye Institute & School of Optometry and Ophthalmology, China
  • Jian-Xing (Jay) Ma
    Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma, United States
  • Xiaorong Li
    Retina, Tianjin Medical University Eye Hospital, Eye Institute & School of Optometry and Ophthalmology, China
  • Footnotes
    Commercial Relationships   Xiaomin Zhang, None; Zhihui Zhang, None; Shuang Chen, None; Nu Chen, None; Jian-Xing (Jay) Ma, None; Xiaorong Li, None
  • Footnotes
    Support  National Natural Science Foundation of China 81671642
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 794. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Xiaomin Zhang, Zhihui Zhang, Shuang Chen, Nu Chen, Jian-Xing (Jay) Ma, Xiaorong Li; Targeting PEDF for the treatment of experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 2019;60(9):794. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Pigment epithelium-derived factor (PEDF) is emerging as a new target for treating many ocular diseases such as diabetic retinopathy and age-related macular degeneration, but the potential role of PEDF in the pathogenesis of uveitis is unclear. To address this issue, we studied experimental autoimmune uveitis (EAU) in wild-type (WT) and PEDF knockout (KO) mice.

Methods : After EAU induction, we compared disease severity in WT and PEDF KO mice using indirect ophthalmoscopy, spectral-domain optical coherence tomography and histopathological analysis. We also explored the underlying mechanism by examining T cell responses in ex vivo antigen-specific recall assays and in vitro T cell priming assays using bone-marrow-derived dendritic cells, splenic dendritic cells, and T cells from WT or PEDF mice. Uveitogenic T cells from WT and PEDF KO mice were adoptively transferred into WT naïve mice to confirm the impact of PEDF on T cells.

Results : We found that PEDF KO mice developed much less severe retinal inflammation than WT mice. We also demonstrated reduced autoreactive T cell responses and decreased retinal T cell infiltration. Furthermore, we confirmed the impaired uveitogenic capacity of T cells from these mice in an adoptive transfer experiment.

Conclusions : Our results strongly suggest that PEDF play a previously unknown but pivotal role in autoimmune uveitis, and may be a promising new treatment target for this human disease.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×